Mergers & Acquisitions


Current filters:


Popular Filters

851 to 875 of 918 results

Covidien to spin off pharmaceuticals business


US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals…

CovidienGenericsMergers & AcquisitionsNeurologicalPharmaceutical

FTC stipulates divestments for Valeant acquisitions


Canada’s Valeant Pharmaceuticals International (TSX: VRX) has been ordered by the USA’s Federal…

DermatologicalsDermikMergers & AcquisitionsNorth AmericaPharmaceuticalValeant Pharmaceuticals

Baxter to acquire Synovis


The USA’s Baxter International (NYSE: BAX) said yesterday that it has reached agreement to acquire…

Baxter InternationalMergers & AcquisitionsPharmaceuticalSynovis Life Technologies

Actelion pulls out of Trophos option


Switzerland-based Actelion (SIX: ATLN), Europe’s biggest biotech company, says that it has decided…

ActelionBiotechnologyLicensingMergers & AcquisitionsolesoximePharmaceuticalRare diseasesTrophos

Sinclair IS buys derma company


UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

AstraZeneca expands in China, cuts back in USA


It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

Generic strategic alliances


The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

Roche acquires Verum Diagnostica for 11 million euros


Swiss drugs and diagnostics major Roche (ROG: SIX) has signed an agreement under which it will acquire…

Mergers & AcquisitionsPharmaceuticalRocheVerum Diagnostica

US Biotech scores wins in November, despite global economic turmoil, says Burrill


Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

Actavis acquires Dutch company PharmaPack


Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack…

ActavisGenericsMergers & AcquisitionsPharmaPack

Further push into diagnostics as Affymetrix acquires eBioscience for $330 million


USA-based Affymetrix (Nasdaq: AFFX) is taking another move into diagnostics, saying that it has signed…

AffymetrixeBioscienceMergers & AcquisitionsPharmaceutical

Further $100 million committed to AstraZeneca’s MedImmune Ventures


Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed yesterday that it has committed an additional…

AstraZenecaFinancialMedImmuneMergers & AcquisitionsPharmaceutical

USA’s SOHM acquires Novatrend to expand presence in India


California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business…

Asia-PacificDermatologicalsGenericsMergers & AcquisitionsNovatrend MedicamentPharmaceuticalSOHM

Asahi Kasei Pharma expands into USA with acquisition of Artisan Pharma


Mid-size Japanese drugmaker Asahi Kasei Pharma says it has acquired its US licensee Artisan Pharma, establishing…

Artisan PharmaAsahi KaseiMergers & AcquisitionsPharmaceuticalRecomodulin

Pfizer to buy Excaliard, gaining rights to Ph II skin scarring product


Global pharma behemoth Pfizer (NYSE: PFE) says it has entered into a definitive agreement to acquire…

DermatologicalsExcaliard PharmaIsis PharmaceuticalsMergers & AcquisitionsPfizerPharmaceutical

UCB adds to CNS portfolio with acquisition of Lectus’ key pharmaceutical assets


Belgian drugmaker UCB (Euronext Brussels: UCB) has acquired the key pharmaceutical assets of closely-held,…

Lectus TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalResearchUCB

Gilead expands hepatitis C R&D portfolio with $11 billion buy of Pharmasset


In its biggest M&D deal to date, Gilead Sciences (Nasdaq: GILD) says it has signed a definitive agreement…

Anti-viralsBiotechnologyGilead SciencesMergers & AcquisitionsmericitabinePharmaceuticalPharmasset

Valeant to acquire Australia’s iNova for up to $946 million


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (NYSE: VRX and TSX: VRX) has signed…

BiotechnologyiNovaMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

India’s new drug price control will damage pharma sector, says local Pfizer chief


The recent moves by India’s government to control the prices of all 348 essential drugs – accounting…

Asia-PacificMergers & AcquisitionsPfizerPharmaceuticalPricing

Lupin acquires Japanese drugmaker I’rom Pharma


Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I’rom…

Asia-PacificGenericsI'rom PharmaceuticalLupinMergers & Acquisitions

Italy’s Menarini takes giant step into Asia-Pacific, with acquisition of Invida


Italy’s leading independent drugmaker Menarini says it has acquired the Singapore-based Invida Group,…

Asia-PacificInvidaMenariniMergers & AcquisitionsPharmaceutical

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business


Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million


UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

851 to 875 of 918 results

Back to top